{
  "id": "adv_mhgap#screening_cues_14e4636a",
  "content": "Hallucinogens Increased heart rate, blood pressure, body temperature, No evidence Acute or chronic psychotic episodes, flashbacks or re-\ndecreased appetite, nausea, vomiting, motor experiencing of drug effects long after termination of use\nincoordination, papillary dilatation, hallucinations\nMDMA Increased self-confidence, empathy, understanding, Nausea, muscle stiffness, headache, loss of appetite, Neurotoxic, leads to behavioral and physiological\nsensation of intimacy, communication, euphoria, energy blurred vision, dry mouth, insomnia, depression, anxiety, consequences, depression\nfatigue, difficulty concentrating\nDISORDERS DUE TO SUBSTANCE USE 115\n116 SUB 1\nDISORDERS DUE TO SUBSTANCE USE Assessment\n1\nCLINICAL TIP\nDoes the person use substances?\nWhile taking a history, ask:\nHow the person started using\nsubstances?\nAsk about use of tobacco, alcohol, and psychoactive prescription\nWhen they started using them?\nmedicines. Depending on the setting and the presentation, consider What was happening in their\nasking about cannabis and other substance use. life at that time?\nIf anyone in their family or\nsocial circle use substances?\nIf they have tried to reduce their\nuse? Why? What happened?\nEmphasise the health benefits of not\nusing psychoactive substances.\nEXIT MODULE\n2\nIs the substance use harmful?\nFor each substance used assess:",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "relationships",
      "emotions",
      "screening_cues"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General â€” Screening Cues Hallucinogens Increased heart rate, blood pressure, body temperature, No evidence Acute or chronic psychotic episodes, flashbacks or re-\ndecreased appetite, nausea, vomiting, motor experiencing of drug effects long after termination of use\nincoordination, papillary dilatation, hallucinations\nMDMA Increased self-confidence, empathy, understanding, Nausea, muscle stiffness, headache, loss of appetite, Neurotoxic, leads to behavioral and physiological\nsensation of intimacy, communication, euphoria, energy blurred vision, dry mouth, insomnia, depression, anxiety, consequences, depression\nfatigue, difficulty concentrating\nDISORDERS DUE TO SUBSTANCE USE 115\n116 SUB 1\nDISORDERS DUE TO SUBSTANCE USE Assessment\n1\nCLINICAL TIP\nDoes the person use substances?\nWhile taking a history, ask:\nHow the person started using\nsubstances?\nAsk about use of tobacco, alcohol, and psychoactive prescription\nWhen they started using them?\nmedicines. Depending on the setting and the presentation, consider What was happening in their\nasking about cannabis and other substance use. life at that time?\nIf anyone in their family or\nsocial circle use substances?\nIf they have tried to reduce their\nuse? Why? What happened?\nEmphasise the health benefits of not\nusing psychoactive substances.\nEXIT MODULE\n2\nIs the substance use harmful?\nFor each substance used assess: Hallucinogens increased heart rate, blood pressure, body temperature, no evidence acute or chronic psychotic episodes, flashbacks or re-\ndecreased appetite, nausea, vomiting, motor experiencing of drug effects long after..."
}